Literature DB >> 29373693

Lung-Derived Exosomal miR-483-3p Regulates the Innate Immune Response to Influenza Virus Infection.

Tadashi Maemura1,2, Satoshi Fukuyama1, Yukihiko Sugita3, Tiago J S Lopes4, Tomomi Nakao1, Takeshi Noda5, Yoshihiro Kawaoka1,2,4.   

Abstract

Exosomes regulate cell-cell communication by transferring functional proteins and RNAs between cells. Here, to clarify the function of exosomes during influenza virus infection, we characterized lung-derived exosomal microRNAs (miRNAs). Among the detected miRNAs, miR-483-3p was present at high levels in bronchoalveolar lavage fluid (BALF) exosomes during infection of mice with various strains of influenza virus, and miR-483-3p transfection potentiated gene expression of type I interferon and proinflammatory cytokine upon viral infection of MLE-12 cells. RNF5, a regulator of the RIG-I signaling pathway, was identified as a target gene of miR-483-3p. Moreover, we found that CD81, another miR-483-3p target, functions as a negative regulator of RIG-I signaling in MLE-12 cells. Taken together, this study indicates that BALF exosomal miRNAs may mediate the antiviral and inflammatory response to influenza virus infection.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29373693     DOI: 10.1093/infdis/jiy035

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  22 in total

1.  Alveolar macrophage-derived extracellular vesicles inhibit endosomal fusion of influenza virus.

Authors:  Daniel J Schneider; Katherine A Smith; Catrina E Latuszek; Carol A Wilke; Danny M Lyons; Loka R Penke; Jennifer M Speth; Matangi Marthi; Joel A Swanson; Bethany B Moore; Adam S Lauring; Marc Peters-Golden
Journal:  EMBO J       Date:  2020-07-09       Impact factor: 11.598

2.  Exosomes transfer miRNAs from cell-to-cell to inhibit autophagy during infection with Crohn's disease-associated adherent-invasive E. coli.

Authors:  Anaïs Larabi; Guillaume Dalmasso; Julien Delmas; Nicolas Barnich; Hang Thi Thu Nguyen
Journal:  Gut Microbes       Date:  2020-06-25

Review 3.  Exosomal miRNAs: novel players in viral infection.

Authors:  Javid Sadri Nahand; Maryam Mahjoubin-Tehran; Mohsen Moghoofei; Mohammad Hossein Pourhanifeh; Hamid Reza Mirzaei; Zatollah Asemi; Alireza Khatami; Farah Bokharaei-Salim; Hamed Mirzaei; Michael R Hamblin
Journal:  Epigenomics       Date:  2020-02-25       Impact factor: 4.778

Review 4.  Interplay between host non-coding RNAs and influenza viruses.

Authors:  Gayan Bamunuarachchi; Samuel Pushparaj; Lin Liu
Journal:  RNA Biol       Date:  2021-01-18       Impact factor: 4.652

Review 5.  Extracellular vesicle-derived miRNA as a novel regulatory system for bi-directional communication in gut-brain-microbiota axis.

Authors:  Liang Zhao; Yingze Ye; Lijuan Gu; Zhihong Jian; Creed M Stary; Xiaoxing Xiong
Journal:  J Transl Med       Date:  2021-05-11       Impact factor: 5.531

Review 6.  Extracellular Vesicle Associated Non-Coding RNAs in Lung Infections and Injury.

Authors:  Zhi Hao Kwok; Kareemah Ni; Yang Jin
Journal:  Cells       Date:  2021-04-21       Impact factor: 7.666

Review 7.  The role of exosomes from BALF in lung disease.

Authors:  Ziyu Liu; Jiaqing Yan; Lingling Tong; Shouyue Liu; Ying Zhang
Journal:  J Cell Physiol       Date:  2021-08-13       Impact factor: 6.513

Review 8.  Potential Role of MicroRNAs in the Regulation of Antiviral Responses to Influenza Infection.

Authors:  Thi Hiep Nguyen; Xiaoming Liu; Zhen Zhong Su; Alan Chen-Yu Hsu; Paul S Foster; Ming Yang
Journal:  Front Immunol       Date:  2018-07-04       Impact factor: 7.561

9.  miR-29a is a negative regulator of influenza virus infection through targeting of the frizzled 5 receptor.

Authors:  Xiaoyun Yang; Yurong Liang; Gayan Bamunuarachchi; Yanzhao Xu; Kishore Vaddadi; Samuel Pushparaj; Dao Xu; Zhengyu Zhu; Rachel Blaha; Chaoqun Huang; Lin Liu
Journal:  Arch Virol       Date:  2020-11-18       Impact factor: 2.574

Review 10.  The potential use of microRNAs as a therapeutic strategy for SARS-CoV-2 infection.

Authors:  Jiulue Hu; Jelena Stojanović; Saman Yasamineh; Pooneh Yasamineh; Sathish Kumar Karuppannan; Mohammed Junaid Hussain Dowlath; Hamed Serati-Nouri
Journal:  Arch Virol       Date:  2021-07-19       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.